当前位置:首页 >财报库 > 报告详情

高乐氏The Clorox Company(CLX)2026财年第二季度财报(10-Q)「NYSE」(英文版)(43页).pdf

上传人: 1****1 编号:1146319 2026-03-02 43页 405.41KB

下载:

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-Q(Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended December 31,2025.OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE A

2、CT OF1934For the transition period from toCommission File Number:1-07151THE CLOROX COMPANY(Exact name of registrant as specified in its charter)Delaware31-0595760(State or other jurisdiction of(I.R.S.Employer Identification No.)incorporation or organization)1221 Broadway,Oakland,California,94612-188

3、8(Address of principal executive offices)(Zip code)(510)271-7000(Registrants telephone number,including area code)(Former name,former address and former fiscal year,if changed since last report)_Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of eac

4、h exchange on which registeredCommon Stock-$1.00 par valueCLXNew York Stock Exchange Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 duringthe preceding 12 months(or for such shorter period that t

5、he registrant was required to file such reports),and(2)has been subject to such filing requirements forthe past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T(232.405

6、 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was required to submit such files).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,smaller reporting company,or anemerging gro

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **财务表现**:2025财年前六个月净销售额31.02亿美元(同比降10%),净利润2.37亿美元(同比降19%);每股收益1.94美元(同比降18%)。 2. **业务分部**:四大报告分部(健康与保健、家居、生活方式、国际)有机销售额均下滑,国际分部表现相对较好(前六个月增长5%)。 3. **重大事件**: - 完成剥离Better Health维生素业务(2024年9月),导致2025财年第一季度录得1.18亿美元税后损失。 - 2026年1月宣布以22.5亿美元收购GOJO Industries,计划通过债务融资完成。 4. **风险与挑战**:宏观经济波动、贸易政策变化及供应链压力持续影响运营,公司预计2026财年环境仍具挑战性。
**Clorox业绩如何?** **GOJO收购影响?** **转型进展怎样?**
客服
商务合作
小程序
服务号
折叠